Get started
Author

Rebecca Christian Arend

Observed names: Arend, Rebecca, Arend, Rebecca C, Arend, Rebecca C., R AREND, R Arend, R. Arend, R.C. Arend, Rebecca C. Arend, Rebecca Arend, Rebecca C Arend, Rebecca C. Arend
Observed institutions: Southern Research Institute, Albert Einstein College of Medicine, Northwell Health, Beth Israel Deaconess Medical Center, Cleveland Clinic, Montefiore Medical Center, University of Alabama at Birmingham Hospital, University of South Carolina, University of Alabama, Columbia University Irving Medical Center, Staten Island University Hospital, University of Alabama at Birmingham, University Hospitals Seidman Cancer Center, Saitama International Medical Center, St Peter's Hospital, Herbert Irving Comprehensive Cancer Center, Case Comprehensive Cancer Center, UAB Medicine, O'Neal Comprehensive Cancer Center, Inner Mongolia Medical University, Columbia University, Saitama Medical University
ORCID: 0000-0003-2108-3426
Observed ORCID: 0000-0003-2108-3426
OpenAlex ID: A5043625183
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
2023 · Nadeem Abu-Rustum, Catheryn Yashar, et al. · Journal of the National Comprehensive Cancer Network · 569
The Wnt/β-catenin pathway in ovarian cancer: A review
2013 · Rebecca C. Arend, Angelina I. Londoño-Joshi, et al. · Gynecologic Oncology · 457
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
2023 · Nadeem R. Abu-Rustum, Catheryn M. Yashar, et al. · Journal of the National Comprehensive Cancer Network · 385
PDF
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 · Yonghe Li, Pui-Kai Li, et al. · Cancer Letters · 364
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
2022 · Mark D Stewart, Diana Merino Vega, et al. · The Oncologist · 237
PDF
Endometrial cancer: Molecular markers and management of advanced stage disease
2018 · Rebecca C. Arend, Bayley A. Jones, et al. · Gynecologic Oncology · 174
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer
2018 · Caroline W Cohen, Kevin R Fontaine, et al. · Journal of Nutrition · 164
PDF
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
2016 · Matthew J. Schultz, Andrew T. Holdbrooks, et al. · Cancer Research · 164
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
2014 · Rebecca C. Arend, Angelina I. Londoño-Joshi, et al. · Gynecologic Oncology · 161
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype
2022 · Camryn M. Cohen, Nicolas Wentzensen, et al. · Journal of Clinical Oncology · 148
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
2022 · Ignace Vergote, Antonio Gonzalez-Martin, et al. · The Lancet Oncology · 139
Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial
2018 · Caroline Cohen, Kevin Fontaine, et al. · Nutrients · 124
PDF
Long-term outcome and natural history of uterine adenosarcomas
2010 · Rebecca Arend, Madhu Bagaria, et al. · Gynecologic Oncology · 115
Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
2018 · Bayley A. Jones, Sooryanarayana Varambally, et al. · Molecular Cancer Therapeutics · 113
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
2021 · Chad A. Hamilton, Bhavana Pothuri, et al. · Gynecologic Oncology · 109
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
2024 · Nadeem R. Abu-Rustum, Catheryn M. Yashar, et al. · Journal of the National Comprehensive Cancer Network · 101
PDF
Failure to Rescue As a Source of Variation in Hospital Mortality for Ovarian Cancer
2012 · Jason D. Wright, Thomas J. Herzog, et al. · Journal of Clinical Oncology · 101
PDF
Effect of Niclosamide on Basal-like Breast Cancers
2014 · Angelina I. Londoño-Joshi, Rebecca C. Arend, et al. · Molecular Cancer Therapeutics · 97
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
2020 · Shannon K Boi, Rachael M Orlandella, et al. · Journal for ImmunoTherapy of Cancer · 94
PDF
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
2016 · Rebecca C. Arend, Angelina I. Londoño-Joshi, et al. · Oncotarget · 84
PDF
B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models
2017 · Benjamin B. Kasten, Rebecca C. Arend, et al. · Nuclear Medicine and Biology · 80
TGFβ signaling networks in ovarian cancer progression and plasticity
2021 · Asha Kumari, Zainab Shonibare, et al. · Clinical & Experimental Metastasis · 79
PDF
Implementation and utilization of the molecular tumor board to guide precision medicine
2017 · Shuko Harada, Rebecca Arend, et al. · Oncotarget · 78
PDF
Uterine carcinosarcoma
2011 · Rebecca Arend, Janine A. Doneza, et al. · Current Opinion in Oncology · 73
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025
2025 · Nadeem R. Abu-Rustum, Susana M. Campos, et al. · Journal of the National Comprehensive Cancer Network · 72
PDF
Works count: 499
Citation count: 7,027
H-index: 45
I10-index: 95
Year
Topic
Type